This topic contains a solution. Click here to go to the answer

Author Question: Which statement describes a correct energy-yielding endpoint? a. Carbohydrates yield glucose only ... (Read 30 times)

berenicecastro

  • Hero Member
  • *****
  • Posts: 581
Which statement describes a correct energy-yielding endpoint?
 
  a. Carbohydrates yield glucose only when proteins are not available.
  b. Proteins cannot yield fat stores.
  c. Fatty acids yield amino acids.
  d. Glycerol yields nonessential amino acids when nitrogen is present.
  e. Fatty acids yield glucose.

Question 2

Which metabolic reaction occurs when a cell uses energy?
 
  a. ATP gains a phosphate group and becomes ADP.
  b. ADP gains a phosphate group and becomes ATP.
  c. ATP releases a phosphate group and becomes ADP.
  d. ADP releases a phosphate group and becomes ATP.
  e. ADP and ATP cycle back and forth repeatedly.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

whitcassie

  • Sr. Member
  • ****
  • Posts: 298
Answer to Question 1

ANS: D

Answer to Question 2

ANS: C




berenicecastro

  • Member
  • Posts: 581
Reply 2 on: Aug 20, 2018
Great answer, keep it coming :)


coreycathey

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

The largest baby ever born weighed more than 23 pounds but died just 11 hours after his birth in 1879. The largest surviving baby was born in October 2009 in Sumatra, Indonesia, and weighed an astounding 19.2 pounds at birth.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library